2 hours Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Rating of “Buy” from Analysts MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy r…